US2005158250A1PendingUtilityA1
Composition of insulin for nasal administration
Priority: Jul 5, 2001Filed: Mar 14, 2005Published: Jul 21, 2005
Est. expiryJul 5, 2021(expired)· nominal 20-yr term from priority
A61K 38/28A61K 9/146A61K 47/38A61P 3/10A61K 9/0043
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided is an insulin-containing granulated composition for nasal administration comprising a crystalline cellulose aggregate having a specific particle diameter distribution as a carrier. Such granulated composition for nasal administration can efficiently increase a blood insulin concentration.
Claims
exact text as granted — not AI-modified1 - 5 . (canceled)
6 . A granulated composition for nasal administration composed of powdered insulin and its carrier, aggregated crystalline cellulose, the distinguishing features of which are that the said insulin is soluble, and that 85 w/w % or more of said crystalline cellulose aggregate has a cribriform particle diameter range of 20-60 μm in one part or across the whole area, and the said granulated composition has a particle diameter falling substantially within the range of that prescribed for the said crystalline cellulose aggregate.
7 . The composition as described in claim 6 having a cribriform particle diameter range distributions of:
w/w % or less of particle diameters below 25 μm, 20-60 w/w % of particle diameters of 25-38 μm, 20-60 w/w % of particle diameters greater than 38 μm and up to 53 μm, and 10 w/w % or less of particle diameters exceeding 53 μm, taking the entire particle as 100%.
8 - 14 . (canceled)Join the waitlist — get patent alerts
Track US2005158250A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.